Anthony Doyle

BCRX

Anthony Doyle serves as Chief Financial Officer at BioCryst Pharmaceuticals, Inc. (BCRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$642.2K

Total Sells

3 trades

$156.7K

Net Position

Net Buyer

$485.5K

Companies Traded

BCRX

Active Period

Nov 2021 – Dec 2024

5 total trades

Most Recent

Sell BCRX

Dec 14, 2024 · $59.4K

Anthony Doyle's Insider Trading at BioCryst Pharmaceuticals, Inc. (BCRX)

Buys

2 · $642.2K

Sells

3 · $156.7K

Total Shares Bought

71,558

Total Shares Sold

19,065

BCRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 14, 2024	Sell	7,890	$7.53	$59.4K
May 14, 2024	Buy	36,300	$5.57	$202.2K
Dec 14, 2023	Sell	5,475	$6.43	$35.2K
Dec 15, 2022	Sell	5,700	$10.90	$62.1K
Nov 23, 2021	Buy	35,258	$12.48	$440.0K